MedPath

Remote Ischemic Conditioning and Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)

Not Applicable
Terminated
Conditions
Atrial Fibrillation
Interventions
Procedure: Sham
Procedure: Remote ischemic conditioning
Registration Number
NCT01107184
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

Recent studies indicate that remote ischemic conditioning can protect the heart and other organs during cardiac surgery. The investigators aim to investigate whether such a stimulus can reduce the incidence of atrial fibrillation or other complications following coronary artery bypass surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
191
Inclusion Criteria
  • Elective on-pump CABG surgery
  • Informed consent
Exclusion Criteria
  • Prior cardiac surgery (Re-operations)
  • Prior atrial fibrillation
  • Use of class 1 or 3 anti arrhythmic medication or digoxin Use of intermittent aortic cross clamping during surgery
  • Age <18 years
  • Left ventricular ejection fraction ≤30%
  • Serious pulmonary disease (resting pO2 <90% at room air)
  • Renal failure (clearance <30 ml/min as calculated using the Modification of Diet in Renal Disease formula)
  • Liver failure
  • Use of the sulfonylurea derivative glibenclamide (this drug is known to block any preconditioning stimulus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlSham-
PostconditioningRemote ischemic conditioningThe remote ischemic stimulus during cardiopulmonary bypass.
PreconditioningRemote ischemic conditioningThe remote ischemic stimulus will be applied after induction of anaesthesia, but before cardiopulmonary bypass.
Pre and postconditioningRemote ischemic conditioningThe remote ischemic stimulus will be applied twice, after induction of anaesthesia and during cardiopulmonary bypass.
Primary Outcome Measures
NameTimeMethod
Post-operative atrial fibrillation72 hours
Secondary Outcome Measures
NameTimeMethod
Major cardiovascular and cerebrovascular events3 months, 6 months, 1 year

Major adverse events, i.e. death, acute coronary syndrome, stroke.

Length of stay1 week on avarage

Duration of hospitalization and stay on the ICU

Trial Locations

Locations (1)

Academic Medical Center, University of Amsterdam

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath